Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$798M |
| 2 |
Netflix
NFLX
|
+$608M |
| 3 |
UnitedHealth
UNH
|
+$517M |
| 4 |
Apple
AAPL
|
+$461M |
| 5 |
GE Vernova
GEV
|
+$296M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$527M |
| 2 |
Alphabet (Google) Class A
GOOGL
|
+$372M |
| 3 |
Meta Platforms (Facebook)
META
|
+$362M |
| 4 |
Advanced Micro Devices
AMD
|
+$328M |
| 5 |
Palantir
PLTR
|
+$327M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.57% |
| 2 | Healthcare | 15.8% |
| 3 | Consumer Discretionary | 12.38% |
| 4 | Financials | 11.53% |
| 5 | Industrials | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
301
ICICI Bank
IBN
$107B
| $55.9M | 0.07% |
+1,662,451
| New | +$55M |
|
302
Lumen
LUMN
$6.58B
| $55.7M | 0.07% |
12,706,609
+1,413,206
| +13% | +$5.48M |
|
303
Vanguard Short-Term Bond ETF
BSV
$45.6B
| $55.6M | 0.07% |
706,900
-577,200
| -45% | -$45.1M |
|
304
D-Wave Quantum Inc. Common Stock
QBTS
$7.53B
| $55.5M | 0.07% |
+3,791,342
| New | +$44.6M |
|
305
BJs Wholesale Club
BJ
$12B
| $55.4M | 0.07% |
513,354
+263,800
| +106% | +$30.1M |
|
306
Five Below
FIVE
$13B
| $55.1M | 0.07% |
420,100
+355,900
| +554% | +$34.7M |
|
307
NiSource
NI
$20.1B
| $55M | 0.07% |
1,364,290
+860,790
| +171% | +$33.8M |
|
308
Entergy
ETR
$49.7B
| $54.9M | 0.07% |
660,913
-362,787
| -35% | -$30M |
|
309
DNOW Inc
DNOW
$3.01B
| $54.8M | 0.07% |
3,695,714
+332,000
| +10% | +$5.07M |
|
310
Royal Gold
RGLD
$19.8B
| $54.8M | 0.07% |
307,933
-43,609
| -12% | -$7.72M |
|
311
Liberty Global Class A
LBTYA
$3.48B
| $54.7M | 0.07% |
5,463,375
+1,358,508
| +33% | +$13.7M |
|
312
Autodesk
ADSK
$53.1B
| $54.6M | 0.07% |
+176,468
| New | +$50.1M |
|
313
Dick's Sporting Goods
DKS
$18.4B
| $54.5M | 0.07% |
275,340
-355,345
| -56% | -$65.8M |
|
314
Agnico Eagle Mines
AEM
$92B
| $54.3M | 0.07% |
456,368
+52,500
| +13% | +$6.09M |
|
|
EXE
315
Expand Energy Corp
EXE
$22.7B
| $54.1M | 0.07% |
462,862
-44,468
| -9% | -$4.96M |
|
316
Dillards
DDS
$10.1B
| $54M | 0.07% |
129,200
+37,500
| +41% | +$14M |
|
317
US Foods
USFD
$23.9B
| $53.7M | 0.07% |
697,300
+221,900
| +47% | +$15.8M |
|
318
ExxonMobil
XOM
$657B
| $53.6M | 0.07% |
496,982
-66,167
| -12% | -$7.07M |
|
319
Mobileye
MBLY
$7.54B
| $53.5M | 0.07% |
2,975,917
+1,638,700
| +123% | +$25M |
|
320
Itron
ITRI
$4.52B
| $53.2M | 0.07% |
403,961
-6,508
| -2% | -$736K |
|
321
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$19.8B
| $53.1M | 0.07% |
1,055,700
-703,800
| -40% | -$35.1M |
|
322
Teva Pharmaceuticals
TEVA
$42.5B
| $52.9M | 0.07% |
3,156,982
-2,144,263
| -40% | -$34.6M |
|
323
AppFolio
APPF
$7.19B
| $52.8M | 0.07% |
229,100
-47,800
| -17% | -$10.4M |
|
324
iShares Short-Term National Muni Bond ETF
SUB
$11.4B
| $52.5M | 0.07% |
493,800
+163,800
| +50% | +$17.3M |
|
|
IPG
325
DELISTED
Interpublic Group of Companies
IPG
| $52.4M | 0.07% |
2,141,400
+292,304
| +16% | +$7.11M |
|
Similar funds
Jim Simons's Q2 2025 Portfolio in Review
As of Q2 2025, Jim Simons held 4,018 positions worth $75.2B, up 14% from $66.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Jim Simons's Q2 2025 filing shows 612 new, 1,577 increased, 1,314 reduced and 496 closed positions. Its largest new stake was UnitedHealth: 1,352,129 shares worth $422M. The largest sale was Broadcom, an estimated $527M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Jim Simons's largest Q2 2025 buy was UnitedHealth: 1,352,129 shares worth $422M.
- Jim Simons added most to NVIDIA in Q2 2025, an estimated $798M increase.
- Jim Simons's biggest Q2 2025 reduction was Broadcom, cutting an estimated $527M.
- Jim Simons fully exited Advanced Micro Devices in Q2 2025, selling an estimated $328M.
- Jim Simons's ten largest holdings make up 12% of its $75.2B portfolio in Q2 2025.
- Jim Simons opened 612 new positions and closed 496 in Q2 2025.
- Jim Simons's portfolio value rose 14% quarter-over-quarter to $75.2B.
Based on Renaissance Technologies's 13F filing for Q2 2025, filed 13 Aug 2025.